摘要
精神分裂症被认为是一种高复发率、高致残率的重性精神疾病,该病患者基数庞大,且预后不良。目前,药物治疗被视为是维持疾病稳定和减少疾病复发的重要手段,社区康复则被视为是大部分患者疾病恢复的一个重要过程。实际上,社区精神分裂症患者存在服药依从性差、家庭监护能力弱、肇事肇祸风险高等问题,不仅不利于患者的病情恢复,也对经济发展和社会稳定构成了威胁。因此,改善社区精神分裂症患者的服药依从性,分析服药依从性的影响因素成为关键。本文就近5年国内外有关社区精神分裂症患者服药依从性状况及其影响因素做一综述,以期为今后的临床研究和相关干预措施提供参考。
Schizophrenia is considered as a severe mental illness with a high recurrence rate and a high disability rate, with a large patient base and a poor prognosis. At present, drug treatment is regarded as an important means to maintain disease stability and reduce disease recurrence, while community rehabilitation is regarded as an important process of disease recovery of most patients. However, in fact, the community patients with schizophrenia have poor medication compliance, weak family monitoring ability, and high risk of causing accidents, which are not only detrimental to the patients’ condition recovery, but also pose a threat to the economic development and social stability. Therefore, how to improve medication compliance for schizophrenic patients and analyze the factors affecting medication adherence become key. This paper summarizes the medication adherence and element of schizophrenia at home and abroad, in order to provide reference for future clinical research and related interventions.
出处
《临床医学进展》
2024年第6期88-93,共6页
Advances in Clinical Medicine
